Alfasigma inaugurates in Pomezia Labio 4.0, a new R&D center

Alfasigma inaugurates in Pomezia Labio 4.0, a new R&D center

Spread the love

Alfasigma inaugurates in Pomezia Labio 4.0, a new R&D center

With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.